Get the Stockscreener App
1.94
0.95%
0.02
Ironwood Pharmaceuticals Inc stock is traded at $1.94, with a volume of 1.94M.
It is up +0.95% in the last 24 hours and up +25.05% over the past month.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
See More
Previous Close:
$1.92
Open:
$1.96
24h Volume:
1.94M
Relative Volume:
1.48
Market Cap:
$314.81M
Revenue:
$400.57M
Net Income/Loss:
$9.21M
P/E Ratio:
48.50
EPS:
0.04
Net Cash Flow:
$146.36M
1W Performance:
+18.91%
1M Performance:
+25.05%
6M Performance:
+107.89%
1Y Performance:
-53.74%
1-Day Range:
$1.80
$2.10
1-Week Range:
$1.4705
$2.10
52-Week Range:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Name
Ironwood Pharmaceuticals Inc
Sector
Phone
617-621-7722
Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.9381 | 311.87M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
144.53 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.3855 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.50 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.52 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-15-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Sep-09-24 | Initiated | Leerink Partners | Market Perform |
| Aug-08-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jan-17-24 | Initiated | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Wells Fargo | Overweight |
| Nov-09-23 | Initiated | Jefferies | Buy |
| Sep-28-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-02-22 | Initiated | CapitalOne | Overweight |
| Apr-22-22 | Initiated | Piper Sandler | Overweight |
| Sep-30-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-20 | Initiated | Northland Capital | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Mar-27-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-25-19 | Upgrade | H.C. Wainwright | Sell → Neutral |
| Jan-24-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-07-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Nov-07-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-23-18 | Initiated | H.C. Wainwright | Sell |
| May-09-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-05-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Dec-06-17 | Downgrade | Mizuho | Buy → Neutral |
| Jul-21-17 | Downgrade | JP Morgan | Overweight → Neutral |
| May-03-17 | Initiated | Wells Fargo | Outperform |
| Apr-07-17 | Reiterated | Mizuho | Buy |
| Feb-22-17 | Reiterated | Barclays | Equal Weight |
| Nov-04-16 | Reiterated | Mizuho | Buy |
| Oct-24-16 | Reiterated | Wedbush | Neutral |
| Oct-10-16 | Reiterated | Mizuho | Buy |
| Sep-27-16 | Reiterated | WallachBeth | Hold |
View All
Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News
Ironwood Pharmaceuticals Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityForecast Cut & Safe Capital Allocation Plans - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yield2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Rally & Advanced Technical Signal Analysis - newser.com
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leader2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Review & AI Driven Price Predictions - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunity2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025July 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025Market Activity Summary & Real-Time Sentiment Analysis - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recovery2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.Analyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.2025 AllTime Highs & Weekly High Return Opportunities - newser.com
Published on: 2025-11-02 02:58:49 - newser.com
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performanceJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 32% - 富途牛牛
Published on: 2025-11-01 04:03:50 - newser.com
Ironwood Pharmaceuticals (IRWD) Surges 28% on Strong Linzess Sal - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominance2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Will Ironwood Pharmaceuticals Inc. bounce back from current supportJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
Ironwood Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Ironwood Pharmaceuticals Inc Stock (IRWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ironwood Pharmaceuticals Inc Stock (IRWD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
1.02%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):